Vesper Healthcare Acquisition has filed to raise $400M in an IPO, with listing on the Nasdaq under the symbol “VSRU.” Goldman Sachs and JPMorgan are underwriting.
Ex-Allergan CEO Brent Saunders is leading the effort, and he’s brought along Manisha Narasimhan, who was SVP of strategic initiatives, portfolio innovation, and investor relations at Allergan.
The focus of Saunders’ SPAC will be medical aesthetics, eyecare, longevity and wellness categories, though it may pursue targets in any industry.
Saunders became CEO of Allergan in 2014 after his generics firm Actavis purchased the company. He departed after the sale to AbbVie (NYSE:ABBV).
https://seekingalpha.com/news/3613269-allergans-ex-ceo-brent-saunders-launching-blank-check-company
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.